RxDoctor Payments Data

Lindsey Becker

Family · Lafayette, INNPI 1366998346

Payments from drug & device makers

$916in general payments, 2019–2025

Across 51 payments — averaging $17.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$388
  • Johnson & Johnson$126
  • Alkermes, Inc.$86
  • Teva Pharmaceuticals USA, Inc.$72
  • Indivior Inc.$67
  • Otsuka America Pharmaceutical, Inc.$52
  • plus $125 from 5 others

What the payments were for

  • Food & beverage$916100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$916 in reported general payments places this provider in the 65th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$3,456
Medicare patients
20
Services billed
40

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate35$68,665
VraylarCariprazine Hcl40$40,383
Abilify MaintenaAripiprazole13$34,368
RexultiBrexpiprazole29$19,043
Ramelteon41$3,089
Venlafaxine Hcl ErVenlafaxine Hcl12$1,855
Lurasidone Hcl13$1,136
Lamotrigine ErLamotrigine12$704
Quetiapine Fumarate ErQuetiapine Fumarate56$693
Olanzapine42$636
Doxepin Hcl37$608
Buspirone Hcl33$579
Naltrexone Hcl22$544
Trazodone Hcl96$403
Duloxetine Hcl44$387

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$52$53,41142 claims
AbbVieVraylar$388$40,38340 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,392 family providers in Indiana.

Other family in Lafayette

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →